InnerScope Hearing Technologies (OTC: INND), an emerging and disruptive leader in the over-the-counter (“OTC”) hearing aid space, has announced its subsidiary HearingAssist, America’s No. 1 affordable OTC hearing aid brand, has launched its FDA-registered OTC rechargeable hearing aids on CVS.com. HearingAssist OTC hearing aids also launched in eight selected CVS pharmacy locations in Massachusetts and Rhode Island. “This latest launch of HearingAssist OTC rechargeable hearing aids with CVS and on CVS.com is a result of our continuing efforts to execute our wholesale distribution plan,” said Matthew Moore, president and CEO of InnerScope. “Having both InnerScope’s Hearing Assist and iHEAR OTC hearing aid brands listed on CVS.com and HearingAssist Rechargeable OTC hearing aids in eight selected CVS pharmacies expands InnerScope’s category presence within CVS’s OTC hearing aid market segment. We believe that when customers compare all the features of HearingAssist and iHEAR OTC hearing aids deliver against the cost and features of the other competitors, we will come out ahead.”

To view the full press release, visit https://ibn.fm/WahTi

About InnerScope Hearing Technologies Inc.

InnerScope is a manufacturer and distributor of OTC hearing aids, hearing aid accessories and hearing health-related products (“hearing products”) dedicated to addressing the global demand for affordable hearing solutions. InnerScope’s hearing products and its B2C and B2B business model break through the persistent barriers that prevent access to effective and affordable hearing solutions. InnerScope’s recent acquisition of iHear Medical Inc., a direct-to-consumer (“DTC”) cloud-based hearing solution provider, gives the company access to over 40 patents and an R&D facility. In addition, InnerScope has acquired HearingAssist, an established leader since 2008 in the DTC hearing aid market, with a customer base of over 400,000. These acquisitions, combined with a partnership with Atlazo Inc., a semiconductor innovator for next-generation AI smart devices, will allow InnerScope to better position itself in the OTC hearing aid market by selling advanced hearing products through Walmart and many other major retailers and pharmacy chains. InnerScope’s full line of hearing products is currently available through these multiple retail/wholesale distribution channels: Walmart Vision Centers, Walmart.com, Walmart Canada, CVS.com, RiteAid.com, BestBuy.com, Amazon.com, Fingerhut.com, Giant Eagle, Hy-Vee, Hartig Drug, Food City, Cardinal Health(TM) at-Home, Carewell.com, FSAStore.com , HSAStore.com, WellDeservedHealth.com, and Topco Associates, representing 1000s of stores. Coming soon: Wakefern Food Corp. / ShopRite / SpartanNash / VG’s Grocery / Family Fare / Martin’s Super Markets. More in-store and online hearing products will soon launch with major retailers and pharmacy chains. For the most up-to-date information about InnerScope, please visit and follow its official Twitter account @inndstock page: https://twitter.com/inndstock.

NOTE TO INVESTORS: The latest news and updates relating to INND are available in the company’s newsroom at https://ibn.fm/INND

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork